Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein

• Susana Guerra ,

  * E-mail: susana.guerra@uam.es (SG); drodrig@cnb.csic.es (DR)

  Affiliations Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain, Department of Preventive Medicine and Public Health, Universidad Autónoma, Madrid, Spain

  ⨯
• Fernando Abaitua,

  Current address: Herpesvirus Molecular Biology, Section of Virology, Department of Medicine, Imperial College London, London, United Kingdom

  Affiliation Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain

  ⨯
• Luis Martínez-Sobrido,

  Affiliation Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Mariano Esteban,

  Affiliation Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain

  ⨯
• Adolfo García-Sastre,

  Affiliations Department of Microbiology, Mount Sinai School of Medicine, New York, New York, United States of America, Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York, United States of America, Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, New York, United States of America

  ⨯
• Dolores Rodríguez

  * E-mail: susana.guerra@uam.es (SG); drodrig@cnb.csic.es (DR)

  Affiliation Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain

  ⨯